JCR Pharmaceuticals Co., Ltd. (JCR)
Market Closed
11 Aug, 06:06
XFRA 
€
2. 70
-0.02
-0.7353%
€
344.02M Market Cap
- P/E Ratio
20% Div Yield
700 Volume
- Eps
€ 2.72
Previous Close Want to track JCR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
JCR Pharmaceuticals Co., Ltd. (JCR) Statistics
Valuation metrics
Market Cap 344.02M
Enterprise value 201.5M
Trailing P/E (ttm) -0.08
Forward P/E -
PEG ratio -
Price/Sales (ttm) 0.01
Price/Book (mrq) 1.59
Enterprise Value/Revenue 1.01
Enterprise Value/EBITDA -17.8
Overview
Shares outstanding 121.98M
Float 71.44M
Shares short -
% Held by insiders 0.42%
% Held by institutions 0.12%
Average volume (10 days) 8
Average volume (90 days) 7
Price summary
52-Week low 2.36
52-Week high 4.22
Beta 0.16
50-Day moving average 3.3
200-Day moving average 3.55
Dividends and splits
Forward annual dividend rate 0.11
Forward annual dividend yield 0.0333%
Trailing annual dividend rate 0.11
Trailing annual dividend yield 0.0333%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 1 Dec 2025
Ex-Dividend Date 29 Sep 2025
Last split factor 4:1
Last split Date 29 Sep 2020
Financials
Fiscal year
Fiscal year ends 31 Mar 2025
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin -0.06%
Operating margin -0.22%
Operational effectiveness
Return on assets -0.03%
Return on equity -0.05%
Income Statement
Revenue (ttm) 200.21M
Revenue per share (ttm) 307.86
Quarterly revenue growth (yoy) -
Gross profit (ttm) 141.06M
EBITDA -11.32M
Net income to common (ttm) -13.01M
Diluted EPS (ttm) -0.1
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 83.42M
Total cash per share (mrq) 128.24
Total debt (mrq) 280.56M
Total Debt/Equity (mrq) 112.55
Current ratio (mrq) 1.16%
Book value per share (mrq) 2.02
Cash Flow
Cash flow statement -5.41B
Levered free cash flow (LFCF) -4.76B
